Ayer Capital Management, Lp, Ten Percent Owner at Iovance Biotherapeutics, holds 2.82M shares in Iovance Biotherapeutics (Ticker: IOVA), holds 3.12M shares in Insmed (Ticker: INSM), holds 2.99M shares in Cascadian Therapeutics (Ticker: CASC). Most recently, Ayer Capital Management, Lp Sold ― shares of Iovance Biotherapeutics on May 06, 2015 for an estimated value of 26.75M.
What is the percentage of profitable transactions made by Ayer Capital Management, Lp?
The percentage of profitable transactions made by Ayer Capital Management, Lp is 82%.
What is the average return per transaction made by Ayer Capital Management, Lp?
The average return per transaction made by Ayer Capital Management, Lp is 30.30%.
What stocks does Ayer Capital Management, Lp hold?
Ayer Capital Management, Lp holds: IOVA, INSM, CASC stocks.
What was Ayer Capital Management, Lp’s latest transaction?
Ayer Capital Management, Lp latest transaction was an Informative Sell of $26.75M.
What was Ayer Capital Management, Lp's most profitable transaction?
Ayer Capital Management, Lp’s most profitable transaction was an Informative Buy of INSM stock on October 8, 2012. The return on the trade was 110.40%.
What is Ayer Capital Management, Lp's role in Iovance Biotherapeutics?
Ayer Capital Management, Lp's role in Iovance Biotherapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.